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Abstract
Sudden arrhythmic cardiac death remains a significant, potentially reversible,
cardiological challenge in terms of creating accurate risk prediction models. The
current guidelines for implantable cardioverter defibrillator (ICD) therapy are
mainly based on left ventricular ejection fraction despite its low sensitivity and
specificity in predicting sudden cardiac death (SCD). Chronic total occlusions
have been associated with increased mortality but further research is required to
clarify if they should be incorporated in a risk model predicting SCD aiming to
identify  patients  that  would benefit  from ICD therapy even with preserved
ejection fraction.
Key words:  Sudden cardiac death; Chronic total occlusion; Left ventricular ejection
fraction; Implantable cardioverter defibrillator
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Core tip: Further research is necessary in order to clarify if chronic total occlusion can
be incorporated in a risk prediction model of sudden cardiac death aiming to identify
patients that would benefit from implantable cardioverter defibrillator.
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INTRODUCTION
Even though death from cardiac causes has been decreasing over the last two decades
in the western world, approximately 20% of all deaths and 50% of cardiovascular
deaths are due to sudden cardiac death (SCD)[1,2]. Coronary chronic total occlusions
(CTO) occur in about 16% of patients with significant ischaemic heart disease and
they  have  been  associated  with  increased  mortality  in  a  large  prospective
observational study[3]. However, currently it is not well known to what extent CTO
increase  SCD and if  these  patients  would benefit  from implantable  cardioverter
defibrillator (ICD) therapy.
In this  Editorial,  we focus on a recent article  by Chi et  al[4]  published in JACC
Clinical Electrophysiology as we feel it provides a new insight into the role of CTO in
relation to prognosis and identifies gaps in knowledge that warrant further research.
In this study the authors aimed to understand the relationship between CTO and the
occurrence  of  ventricular  tachycardia/fibrillation  (VT/VF)  or  appropriate  ICD
therapy. They performed a meta-analysis including a total of 17 studies involving
almost 55 thousand patients. They found that the presence of CTO was associated
with higher risk of VT/VF or appropriate ICD therapy; however it was not associated
with a difference in cardiac mortality or in all-cause mortality. The higher risk of
VT/VF  or  appropriate  ICD  therapy  was  confirmed  on  both  univariate  and
multivariate analysis (in only two studies), while the risk of cardiac mortality was
significantly higher on univariate but not on multivariate analysis and the risk of all-
cause mortality  was not  significantly  higher  in  either  univariate  or  multivariate
analysis[4].
Comparing  patients  with  infarct-related  and  non-infarct  related  CTOs,  they
concluded that the former had a higher risk of VT/VF or appropriate ICD therapy,
cardiac  mortality  and  higher  all-cause  mortality.  The  higher  risk  of  VT/VF  or
appropriate ICD therapy of patients with infarct-related CTOs was confirmed on
univariate but not multivariate analysis while the higher risk of cardiac mortality was
only significant on multivariate analysis and the higher risk of all-cause mortality was
significant  on  both  univariate  and  multivariate  analysis.  Finally,  non-
revascularization of CTO was associated with higher risk of all-cause mortality but
this did not reach statistical significance. The authors reached the conclusion that ICD
implantation for primary or secondary prevention should be considered in patients
who have infarct-related CTOs[4].
According to American Heart Association/American College of Cardiology/ Heart
Rhythm Society (AHA/ACC/HRS) 2017, European Society of Cardiology (ESC) 2015
and United Kingdom National Institute for Health and Clinical Excellence (NICE)
2014 guidelines, an ICD is indicated for secondary prevention in survivors of cardiac
arrest provided there is no reversible cause[5-7]. The decision for primary prevention
ICD therapy varies slightly according to the various guidelines however, in general it
depends on the left ventricular ejection fraction (LVEF), QRS duration and New York
Heart Association (NYHA) class. The AHA/ACC/HRS 2017 guidelines recommend
ICD if LVEF < 35% and NYHA II-III  or LVEF < 30% and NYHA I.  The ESC 2015
guidelines recommend ICD if LVEF < 35% and NYHA II-III[5]. According to NICE
2014 guidelines, primary prevention ICD therapy is indicated if LVEF < 35%, NYHA
I-III and QRS duration > 120 ms. For patients who fulfil the first two criteria but QRS
is < 120 ms, ICD is recommended if there is a high risk of SCD[7] and in this situation
the  current  research[4]  would  perhaps  suggest  that  presence  of  CTO  can  be  a
qualifying criterion for “high risk”[7].
Even though LVEF has a central role in the algorithm for recommending primary
prevention ICD therapy, it has both low specificity and sensitivity for predicting SCD.
It  is  established  that  low  LVEF  predicts  not  only  SCD  but  also  other  modes  of
cardiovascular death as well[8]. In addition, only a minority of patients who suffer
cardiac arrest will have LVEF < 35%. It is estimated that 40% of patients who suffer
SCD have known heart disease with LVEF > 40%, while only 13% of patients who
suffer SCD have known heart disease and LVEF < 40%[2]. It has also been shown that
myocardial  scar  >  5%  is  an  independent  risk  factor  for  all-cause  mortality  and
appropriate  ICD  therapy,  irrespective  of  LVEF[9].  In  addition,  looking  at  other
pathologies  for  example  dilated  cardiomyopathy[10]  and  aortic  stenosis[11],  other
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parameters  such  as  presence  of  myocardial  fibrosis  have  been  shown  to  have
additional prognostic impact over and above LVEF.
CONCLUSION
Chi et al[4] have analysed 17 studies that had included patients with severely reduced
LVEF but also patients with only mildly reduced or even normal LVEF. It remains to
be  seen  whether  CTO  can  be  regarded  as  an  independent  factor  for  malignant
arrhythmias  over  and above  the  information  we  get  from LVEF,  but  this  study
certainly suggests that this should be investigated. In addition, further research can
identify whether patients who have viable myocardium with evidence of reversible
ischaemia in the presence of some myocardial scar in the CTO territory should also be
considered for an ICD even after successful revascularisation. Even though we do not
feel that definitive conclusions can be drawn from this analysis, it is an important
study as it indicates that further research is needed in order to clarify the relationship
of infarct-related CTO and non-infarct related CTO with SCD both in patients with
reduced and preserved LVEF. It is well appreciated that the risk of SCD is continuous
rather than dichotomous and no single parameter can adequately discriminate to
dichotomise the risk[12]. Therefore, clarification if CTO is a high risk variable for SCD
in patients  with preserved LVEF (introducing a  new term for  such patients,  the
CTOpEF patients) or mid-range EF (CTOmrEF patients) or in patients with LVEF <
35% and narrow QRS would be very clinically relevant.
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